Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries... Show more
Perimeter Group operates across two reporting segments: Fire Safety and Specialty Products. Within Fire Safety, its portfolio spans long-term fire retardants, firefighting foam concentrates, and complementary equipment and services, anchored by brands such as Perimeter Solutions, Solberg Fire, and Monaco Enterprises. This gives the company a meaningful position in a niche, mission-critical market where regulatory standards, agency relationships, and formulation expertise create barriers to entry.
The Specialty Products segment — including PDI, MMT, and IMS — extends the company into phosphorus-based lubricant additives and other industrial applications. This diversification is strategically important: it reduces reliance on a single, weather-dependent demand driver and positions the business to capture steadier, less seasonal revenue streams. Management's push into adjacent, high-value niches, including the acquisition of Medical Manufacturing Technologies, signals an ambition to build a broader industrial platform rather than remain a pure-play fire safety operator.
Still, the company's market positioning carries structural considerations. Fire safety revenue remains sensitive to the intensity of wildfire seasons, while Specialty Products demand can track industrial production and customer inventory cycles. Sustaining a competitive edge will depend on continued innovation in formulation chemistry, disciplined pricing, and successful integration of acquired businesses.
Several developments could shape investor sentiment around the stock forecast in the coming quarters. First, the multi-year USDA agreement provides a foundation of demand visibility, but the cadence of fire activity during peak wildfire months will remain a recurring catalyst for both revenue and margins.
Second, quarterly earnings releases remain pivotal. Because the business is seasonal, results and guidance tied to fire season severity and Specialty Products volumes will be closely scrutinized. Third, capital allocation will be a focus: investors will watch how management funds and integrates recent acquisitions, manages leverage, and whether it pursues additional bolt-on deals to broaden its platform.
On the analyst front, sentiment has shifted in both directions over the past year. Morgan Stanley initiated coverage with an Overweight (Buy-equivalent) rating and a $35 price target in late 2025, while UBS moved from Buy to Neutral in early 2026 even as it raised its target to $31 — a pattern that reflects confidence in the company's operating momentum tempered by valuation concerns after a substantial share-price advance. Consensus data indicates an average rating of "Buy" among covering analysts, with a 12-month average price target above recent trading levels. This mixed but generally constructive profile suggests that analyst ratings and price targets are being recalibrated around execution rather than a broad directional shift.
The company's trajectory is closely linked to climate and public-safety spending. Rising wildfire frequency and intensity in North America and internationally have increased demand for retardants and suppression services, a structural tailwind that supports multi-year procurement commitments from government agencies. Fiscal priorities around wildfire preparedness and disaster response will therefore matter directly to the Fire Safety segment's outlook.
Broader macroeconomic conditions also play a role. The Specialty Products business is exposed to industrial production cycles, customer de-stocking or restocking behavior, and input cost inflation. Higher interest rates can raise the cost of capital for acquisitions and weigh on valuation multiples for growth-oriented industrial companies. Meanwhile, raw material and logistics costs can pressure margins if pricing power lags input-cost increases. Regulatory developments affecting chemical formulations and environmental standards represent both a compliance burden and, for a company with strong technical capabilities, a potential competitive advantage.
For investors seeking a data-driven view of where a stock may head next, Tickeron's Trend Prediction Engine offers an AI-powered forecasting approach. The tool is designed to help traders assess whether a stock, exchange-traded fund (ETF), or other asset may trend bullish, bearish, or sideways over the coming week or month. By analyzing patterns, the engine aims to help users spot developing trends, evaluate potential breakouts or reversals, and explore predictions across a broad universe of tradable instruments. Its searchable categories, historical context, and alert-oriented functionality can support more informed decision-making. To explore how this tool evaluates PRM and other tickers, visit the Trend Prediction Engine.
Looking ahead to 2026 and beyond, several structural themes are likely to define the company's future outlook. The first is portfolio diversification: continued expansion into specialty products and medical manufacturing could smooth earnings volatility and support more predictable long-term growth, while also shifting how the market values the business.
The second is cost structure and margin sustainability. As acquisitions are integrated, investors will focus on whether adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) margins can hold or expand, and whether synergies materialize on schedule. The third is technology and formulation transitions, including emerging applications for phosphorus-based chemistries, which could open new end markets over time.
Competitive and regulatory factors will also shape the long-term path. Heightened competition in specialty chemicals and evolving environmental standards could pressure returns if not managed effectively. Finally, capital allocation priorities — balancing debt reduction, internal investment, and further acquisitions — will influence both earnings growth and valuation. Consensus analyst expectations appear generally optimistic on the company's direction, but the stock's premium valuation means sustained execution will be essential to support sentiment. These are considerations for any investor weighing the company's longer-term growth catalysts and risks.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| USTB | 50.08 | 0.11 | +0.22% |
| VictoryShares Short-Term Bond ETF (USTB) | |||
| NBB | 13.92 | 0.01 | +0.07% |
| Nuveen Taxable Municipal Income Fund | |||
| RKNG | 25.19 | N/A | N/A |
| Defiance Retail Kings ETF | |||
| DECT | 37.06 | -1.06 | -2.77% |
| AllianzIM U.S. Equity Buffer10 Dec ETF (DECT) | |||
| BAMG | 39.77 | -1.83 | -4.40% |
| Brookstone Growth Stock ETF (BAMG) | |||
A.I.dvisor indicates that over the last year, PRM has been loosely correlated with OLN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PRM jumps, then OLN could also see price increases.
Industry ChemicalsSpecialty
PRM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 20, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In 38 of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 88%.
The 10-day RSI Indicator for PRM moved out of overbought territory on November 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 25 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 34 of 52 cases where PRM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.
The Momentum Indicator moved below the 0 level on November 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PRM as a result. In 63 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
PRM moved below its 50-day moving average on November 20, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
PRM broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The 10-day moving average for PRM crossed bullishly above the 50-day moving average on November 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
Following a +12.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRM advanced for three days, in 242 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 202 of 237 cases where PRM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. PRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.727) is normal, around the industry mean (2.284). P/E Ratio (-13.288) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (6.566) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.